{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:35:42Z","timestamp":1792794942392,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Veterans Affairs Health Services Research and Development Award","award":["IIR-13-314"],"award-info":[{"award-number":["IIR-13-314"]}],"id":[{"id":"https:\/\/ror.org\/0083hz885","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Division of Rheumatology at the University of Alabama at Birmingham and the resources and use of facilities at the Birmingham VA Medical Center","id":[{"id":"https:\/\/ror.org\/008s83205","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim was to examine the views of health-care providers regarding disease modification in gout, with the potential to derive a provisional set of domains for disease modification in gout.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A qualitative nominal group study was performed with 20 gout experts (15 expert\/expert panel members of the 2012 and\/or 2020 ACR gout guidelines and\/or 2015 ACR\/EULAR gout classification criteria) about what constitutes disease modification in gout: \u2018What sorts of things do you think constitute a change in the course of disease in gout? (positive); what are all the ways in which gout as a disease can be modified?\u2019<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Decrease in gout flares was rated number one rank in all six nominal groups as indicative of disease modification in gout, followed by serum urate lowering, which was rated number one rank in one of the six nominal groups (tied score with flares in one nominal group). Other components of gout disease modification were to improve quality of life\/productivity; restore function; reduce\/eliminate pain; reduce tophi burden; and joint preservation or resolution of joint damage. Potential additional components that were not ranked in the top three votes within each nominal group were: decreasing health-care cost\/utilization; reducing cardiovascular\/renal morbidity\/mortality; and stopping formation of urate crystals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This qualitative study provides a provisional set of domains for disease modification in gout. Future studies for the development of thresholds for disease modification domains and wider consensus on this definition are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkab107","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T12:44:09Z","timestamp":1641213849000},"source":"Crossref","is-referenced-by-count":7,"title":["Disease modification in gout: a qualitative study of gout expert rheumatologists"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-0006","authenticated-orcid":false,"given":"Jasvinder A","family":"Singh","sequence":"first","affiliation":[{"name":"Medicine Service, Birmingham VA Medical Center"},{"name":"Department of Medicine at School of Medicine, and Division of Epidemiology at School of Public Health, University of Alabama, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"2022011117500955500_rkab107-B1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022011117500955500_rkab107-B2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22741","article-title":"Development of preliminary remission criteria for gout using Delphi and 1000Minds Consensus Exercises","volume":"68","author":"de Lautour","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022011117500955500_rkab107-B3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13075-019-1941-8","article-title":"Concurrent validity of provisional remission criteria for gout: a dual-energy CT study","volume":"21","author":"Dalbeth","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2022011117500955500_rkab107-B4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/RHU.0000000000000981","article-title":"Patient perceptions of gout management goals: a cross-sectional internet survey","volume":"26","author":"Singh","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"2022011117500955500_rkab107-B5","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s10067-018-4243-7","article-title":"Goals of gout treatment: a patient perspective","volume":"37","author":"Singh","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2022011117500955500_rkab107-B6","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"2022011117500955500_rkab107-B7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"key":"2022011117500955500_rkab107-B8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022011117500955500_rkab107-B9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rdc.2005.09.005","article-title":"The definition and measurement of disease modification in inflammatory rheumatic diseases","volume":"32","author":"Aletaha","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"2022011117500955500_rkab107-B10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.evalprogplan.2009.11.002","article-title":"Use of the Nominal Group Technique (NGT) to understand the perceptions of the healthiness of foods associated with African Americans","volume":"33","author":"Jefferson","year":"2010","journal-title":"Eval Program Plann"},{"key":"2022011117500955500_rkab107-B11","first-page":"974964","article-title":"A patient-based needs assessment for living well with Parkinson disease: implementation via Nominal Group Technique","volume":"2013","author":"Kleiner-Fisman","year":"2013","journal-title":"Parkinsons Dis"},{"key":"2022011117500955500_rkab107-B12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/146642409611600303","article-title":"Identifying problems in community health promotion: an illustration of the Nominal Group Technique in AIDS education","volume":"116","author":"MacLachlan","year":"1996","journal-title":"J R Soc Health"},{"key":"2022011117500955500_rkab107-B13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/014572170002600211","article-title":"Nominal group technique: a process for identifying diabetes self-care issues among patients and caregivers","volume":"26","author":"Miller","year":"2000","journal-title":"Diabetes Educ"},{"key":"2022011117500955500_rkab107-B14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00520-009-0721-4","article-title":"Outcome indicators in palliative care\u2014how to assess quality and success. Focus group and nominal group technique in Germany","volume":"18","author":"Pastrana","year":"2010","journal-title":"Support Care Cancer"},{"key":"2022011117500955500_rkab107-B15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jhm.1900","article-title":"Nominal group technique: a brainstorming tool for identifying areas to improve pain management in hospitalized patients","volume":"7","author":"Pena","year":"2012","journal-title":"J Hosp Med"},{"key":"2022011117500955500_rkab107-B16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1467-842X.1997.tb01695.x","article-title":"Consulting about priorities for the NHMRC National Breast Cancer Centre: how good is the nominal group technique","volume":"21","author":"Redman","year":"1997","journal-title":"Aust N Z J Public Health"},{"key":"2022011117500955500_rkab107-B17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/RHU.0000000000000091","article-title":"Challenges faced by patients in gout treatment: a qualitative study","volume":"20","author":"Singh","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"2022011117500955500_rkab107-B18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1213\/ANE.0000000000004872","article-title":"Pediatric airway management in COVID-19 patients: consensus guidelines from the society for pediatric anesthesia's Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society","volume":"131","author":"Matava","year":"2020","journal-title":"Anesth Analg"},{"key":"2022011117500955500_rkab107-B19","first-page":"59","article-title":"Nutritional support for patients recovering from COVID-19. A consensus process with health and social care sector representatives","volume":"34","author":"Hickson","year":"2021","journal-title":"S Afr J Clin Nutr"},{"key":"2022011117500955500_rkab107-B20","doi-asserted-by":"crossref","first-page":"e052593","DOI":"10.1136\/bmjopen-2021-052593","article-title":"Nominal group technique to establish the core components of home-based rehabilitation for survivors of stroke with severe disability","volume":"11","author":"Fisher","year":"2021","journal-title":"BMJ Open"},{"key":"2022011117500955500_rkab107-B21","first-page":"1381","article-title":"Outcome evaluations in gout","volume":"34","author":"Schumacher","year":"2007","journal-title":"J Rheumatol"},{"key":"2022011117500955500_rkab107-B22","first-page":"2452","article-title":"Outcome measures for acute and chronic gout","volume":"32","author":"Schumacher","year":"2005","journal-title":"J Rheumatol"},{"key":"2022011117500955500_rkab107-B23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.40381","article-title":"Brief report: validation of a definition of flare in patients with established gout","volume":"70","author":"Gaffo","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2022011117500955500_rkab107-B24","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/art.33483","article-title":"Developing a provisional definition of flare in patients with established gout","volume":"64","author":"Gaffo","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022011117500955500_rkab107-B25","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1186\/ar4589","article-title":"The impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout","volume":"16","author":"Singh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2022011117500955500_rkab107-B26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/ard.2007.079970","article-title":"A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout","volume":"67","author":"Taylor","year":"2008","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkab107\/42027347\/rkab107.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/6\/1\/rkab107\/42097691\/rkab107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/6\/1\/rkab107\/42097691\/rkab107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T14:16:12Z","timestamp":1641910572000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkab107\/6493379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkab107","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022]]},"published":{"date-parts":[[2022]]},"article-number":"rkab107"}}